Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels
Study Information
Alliance Study ID: CALGB-79806
NCT Study ID (ClinicalTrials.gov): NCT00031746
Alliance Committee: Cancer Control
Disease or Cancer Type: Prostate Cancer
Alliance Study Chair: James L. Mohler, MD
Status: COMPLETED
Study Description
RATIONALE: Soy protein supplement may prevent or delay the development of prostate cancer in patients who have elevated prostate-specific antigen (PSA) levels.
PURPOSE: Randomized phase II trial to determine the effectiveness of soy protein supplement in preventing prostate cancer in patients who have elevated PSA levels.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information